2,4-pyridinedicarboxylic acid has been researched along with 3-[[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Brennan, PE; Burgess-Brown, NA; Che, K; Daniel, M; England, KS; Kawamura, A; Krojer, T; Ng, SS; Schofield, CJ; Scozzafava, G; Szykowska, A; Tumber, A; von Delft, F | 1 |
Athanasou, N; Badock, V; Brennan, PE; Brown, J; Burgess-Brown, N; Egner, U; Gileadi, C; Hookway, ES; Johansson, C; Kopec, J; LaThangue, NB; Munro, S; Nowak, RP; Nuzzi, A; Oppermann, U; Philpott, M; Prinjha, R; Steuber, H; Strain-Damerell, C; Szykowska, A; Tumber, A; Velupillai, S; Westaway, S; Wu, N | 1 |
Abboud, MI; Langley, GW; Lohans, CT; Schofield, CJ | 1 |
Andrijes, R; Ansari, MSZ; Antonini, L; Ciogli, A; Coleman, ML; Del Bufalo, D; Hendrix, E; Johansson, C; Kawamura, A; Mai, A; Mautone, N; Nowak, RP; Oppermann, U; Passeri, D; Pellegrini, FR; Pellicciari, R; Ragno, R; Rotili, D; Sabatino, M; Salah, E; Schofield, CJ; Simelis, K; Trisciuoglio, D; Tumber, A | 1 |
4 other study(ies) available for 2,4-pyridinedicarboxylic acid and 3-[[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acid
Article | Year |
---|---|
Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor.
Topics: | 2014 |
Structural analysis of human KDM5B guides histone demethylase inhibitor development.
Topics: Antineoplastic Agents; Cell Proliferation; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Models, Molecular; Multiple Myeloma; Nuclear Proteins; Protein Conformation; Repressor Proteins; Structure-Activity Relationship | 2016 |
Inhibition of a viral prolyl hydroxylase.
Topics: Enzyme Assays; Hydroxylation; Hypoxia-Inducible Factor-Proline Dioxygenases; Ketoglutaric Acids; Oligopeptides; Phycodnaviridae; Procollagen-Proline Dioxygenase; Prolyl-Hydroxylase Inhibitors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2019 |
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53.
Topics: Cell Line, Tumor; Cell Proliferation; Crystallization; Dioxygenases; Enzyme Inhibitors; Histone Demethylases; Humans; Models, Molecular; Nuclear Proteins; Protein Conformation; Ribosomes; Substrate Specificity | 2021 |